Serum uric acid and diabetes: from pathophysiology to cardiovascular disease

N Katsiki, GD Dimitriadis… - Current pharmaceutical …, 2021 - ingentaconnect.com
Hyperuricemia, has been traditionally related to nephrolithiasis and gout. However, it has
also been associated with the development of type 2 diabetes mellitus (T2DM) and …

Association of sodium-glucose transport protein 2 inhibitor use for type 2 diabetes and incidence of gout in Taiwan

MC Chung, PH Hung, PJ Hsiao, LY Wu… - JAMA network …, 2021 - jamanetwork.com
Importance The use of sodium-glucose transport protein 2 (SGLT2) inhibitors is currently a
standard intervention in patients with type 2 diabetes (T2DM) and exerts favorable …

Vildagliptin plasticized hydrogel film in the control of ocular inflammation after topical application: study of hydration and erosion behaviour

S Nandi, A Ojha, A Nanda, RN Sahoo… - Zeitschrift für …, 2022 - degruyter.com
Vildagliptin (VID) is a dipeptidyl peptidase-4 (DPP-4) inhibitor used in controlling blood
glucose level in type 2 diabetes. Vildagliptin improves beta cells function and is also …

Isolation and Quantification of Palmatine from Fibraurea tinctoria Lour: In Vitro Antioxidant Activity and In Silico Antidiabetic Activity Evaluation

I Purwaningsih, IP Maksum, D Sumiarsa… - Drug Design …, 2024 - Taylor & Francis
Purpose This study aimed to isolate and characterize palmatine from Fibraurea tinctoria
Lour stems, quantify its content, and determine its antioxidant and antidiabetic activities …

Comparison of empagliflozin and vildagliptin for efficacy and safety in type 2 diabetes mellitus in the Pakistani population

A Khan, IA Khan, H Abidi, M Ahmed - Frontiers in Endocrinology, 2022 - frontiersin.org
Background Diabetes mellitus (DM) is a chronic disease that needs early management to
prevent complications and premature mortality. Therefore, it is essential to select evidence …

Effects of vildagliptin on wound healing and markers of inflammation in patients with type 2 diabetic foot ulcer: a prospective, randomized, double-blind, placebo …

VN Vangaveti, S Jhamb, O Hayes, J Goodall… - Diabetology & Metabolic …, 2022 - Springer
Introduction Diabetic foot ulcers (DFU) are one of the leading long-term complications
experienced by patients with diabetes. Dipeptidyl Peptidase 4 inhibitors (DPP4is) are a …

[HTML][HTML] Dipeptidyl Peptidase-4 Inhibitors and Inflammation: Dpp-4 Inhibitors Improve Mean Pleatelet Volume and Gamma Glutamyl Transferase Level

D Avcı - Journal of Biosciences and Medicines, 2019 - scirp.org
AIM: The purpose of this research was to determine the changes of the inflammatory
parameters in the long term with the use of dipeptidyl peptidase-4 inhibitors. Material and …

Vitamin D3 potentiates the renoprotective effects of vildagliptin in a rat model of fructose/salt-induced insulin resistance

NS Wahba, RH Abdel-Ghany, SA Ghareib… - European Journal of …, 2020 - Elsevier
Insulin resistance (IR) seemingly plays a role in chronic kidney disease (CKD). The present
study has elucidated the crucial interplay of oxidative stress, inflammatory, apoptotic and …

Vitamin D3 potentiates the nephroprotective effects of vildagliptin–metformin combination in a rat model of metabolic syndrome

NS Wahba, RH Abdel‐Ghany… - Fundamental & …, 2022 - Wiley Online Library
The current study was conducted to investigate the nephroprotective effects of vildagliptin–
metformin combination in an experimental model of fructose/salt‐induced metabolic …

[HTML][HTML] Развитие сахарного диабета 2-го типа при подагре

ОВ Желябина, МС Елисеев - Научно-практическая ревматология, 2021 - cyberleninka.ru
Подагра-наиболее часто встречающийся у взрослых воспалительный артрит,
распространенность которого продолжает увеличиваться в течение последних …